Literature DB >> 30644449

DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Søren R Paludan1,2, Line S Reinert3, Veit Hornung4,5.   

Abstract

The immune system detects disturbances in homeostasis that occur during infection, sterile tissue damage and cancer. This initiates immune responses that seek to eliminate the trigger of immune activation and to re-establish homeostasis. At the same time, these mechanisms can also play a crucial role in the progression of disease. The occurrence of DNA in the cytosol constitutes a potent trigger for the innate immune system, governing the production of key inflammatory cytokines such as type I interferons and IL-1β. More recently, it has become clear that cytosolic DNA also triggers other biological responses, including various forms of programmed cell death. In this article, we review the emerging literature on the pathways governing DNA-stimulated cell death and the current knowledge on how these processes shape immune responses to exogenous and endogenous challenges.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30644449      PMCID: PMC7311199          DOI: 10.1038/s41577-018-0117-0

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  164 in total

1.  Foreign nucleic acids as the stimulus to make interferon.

Authors:  A ISAACS; R A COX; Z ROTEM
Journal:  Lancet       Date:  1963-07-20       Impact factor: 79.321

Review 2.  Pathogenesis of Sjögren's syndrome.

Authors:  Nikolay P Nikolov; Gabor G Illei
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

3.  Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA.

Authors:  Leticia Corrales; Seng-Ryong Woo; Jason B Williams; Sarah M McWhirter; Thomas W Dubensky; Thomas F Gajewski
Journal:  J Immunol       Date:  2016-02-29       Impact factor: 5.422

4.  Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection.

Authors:  Nicole Schmitz; Michael Kurrer; Martin F Bachmann; Manfred Kopf
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

Authors:  Seng-Ryong Woo; Mercedes B Fuertes; Leticia Corrales; Stefani Spranger; Michael J Furdyna; Michael Y K Leung; Ryan Duggan; Ying Wang; Glen N Barber; Katherine A Fitzgerald; Maria-Luisa Alegre; Thomas F Gajewski
Journal:  Immunity       Date:  2014-11-05       Impact factor: 31.745

6.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

7.  Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Ying K Huang; Daniel C Bertolette; Francis W Ruscetti
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

8.  STING Senses Microbial Viability to Orchestrate Stress-Mediated Autophagy of the Endoplasmic Reticulum.

Authors:  Julien Moretti; Soumit Roy; Dominique Bozec; Jennifer Martinez; Jessica R Chapman; Beatrix Ueberheide; Dudley W Lamming; Zhijian J Chen; Tiffany Horng; Garabet Yeretssian; Douglas R Green; J Magarian Blander
Journal:  Cell       Date:  2017-10-19       Impact factor: 41.582

9.  Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

Authors:  Huayi Wang; Liming Sun; Lijing Su; Josep Rizo; Lei Liu; Li-Feng Wang; Fu-Sheng Wang; Xiaodong Wang
Journal:  Mol Cell       Date:  2014-04-03       Impact factor: 17.970

10.  AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA.

Authors:  Teresa Fernandes-Alnemri; Je-Wook Yu; Pinaki Datta; Jianghong Wu; Emad S Alnemri
Journal:  Nature       Date:  2009-01-21       Impact factor: 49.962

View more
  46 in total

1.  Harnessing radiation to improve immunotherapy: better with particles?

Authors:  Marco Durante; Silvia Formenti
Journal:  Br J Radiol       Date:  2019-07-22       Impact factor: 3.039

2.  Macrophage migration inhibitory factor enhances influenza-associated mortality in mice.

Authors:  Candice A Smith; Daniel J Tyrell; Upasana A Kulkarni; Sherri Wood; Lin Leng; Rachel L Zemans; Richard Bucala; Daniel R Goldstein
Journal:  JCI Insight       Date:  2019-07-11

3.  Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury.

Authors:  Matthew D Fountain; Laura A McLellan; Natalie L Smith; Brian F Loughery; Joseph T Rakowski; Harley Y Tse; Gilda G Hillman
Journal:  Int J Radiat Biol       Date:  2019-11-04       Impact factor: 2.694

4.  Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice.

Authors:  Sikai Ling; Shiqi Yang; Xinde Hu; Di Yin; Yao Dai; Xiaoqing Qian; Dawei Wang; Xiaoyong Pan; Jiaxu Hong; Xiaodong Sun; Hui Yang; Soren Riis Paludan; Yujia Cai
Journal:  Nat Biomed Eng       Date:  2021-01-04       Impact factor: 25.671

5.  Upregulation of necroptosis markers RIPK3/MLKL and their crosstalk with autophagy-related protein Beclin-1 in primary immune thrombocytopenia.

Authors:  Amany M Kamal; Nermeen A Nabih; Nahed M Rakha; Eman F Sanad
Journal:  Clin Exp Med       Date:  2022-06-14       Impact factor: 3.984

6.  NEDD9 links anaplastic thyroid cancer stemness to chromosomal instability through integrated centrosome asymmetry and DNA sensing regulation.

Authors:  Henry G Yu; Krikor Bijian; Sabrina D da Silva; Jie Su; Gregoire Morand; Alan Spatz; Moulay A Alaoui-Jamali
Journal:  Oncogene       Date:  2022-04-22       Impact factor: 9.867

7.  The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.

Authors:  Martin K Thomsen; Morten K Skouboe; Cedric Boularan; Fabienne Vernejoul; Thierry Lioux; Siv L Leknes; Martin F Berthelsen; Maria Riedel; Huiqiang Cai; Justin V Joseph; Eric Perouzel; Michele Tiraby; Mikkel H Vendelbo; Søren R Paludan
Journal:  Oncogene       Date:  2019-11-18       Impact factor: 9.867

Review 8.  Inflammatory microenvironment remodelling by tumour cells after radiotherapy.

Authors:  Martin McLaughlin; Emmanuel C Patin; Malin Pedersen; Anna Wilkins; Magnus T Dillon; Alan A Melcher; Kevin J Harrington
Journal:  Nat Rev Cancer       Date:  2020-03-11       Impact factor: 60.716

Review 9.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

10.  Characterization of DNA-protein complexes by nanoparticle tracking analysis and their association with systemic lupus erythematosus.

Authors:  Kristian Juul-Madsen; Anne Troldborg; Thomas R Wittenborn; Mads G Axelsen; Huaying Zhao; Lasse H Klausen; Stefanie Luecke; Søren R Paludan; Kristian Stengaard-Pedersen; Mingdong Dong; Holger J Møller; Steffen Thiel; Henrik Jensen; Peter Schuck; Duncan S Sutherland; Søren E Degn; Thomas Vorup-Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.